Financhill
Back

Aptevo Therapeutics Vs. Novo Nordisk AS Industry Stock Comparison

Sell
27

APVO
Aptevo Therapeutics

Last Price:
$4.36
Seasonality Move:
-31.63%
Sell
23

NVO
Novo Nordisk AS

Last Price:
$85.00
Seasonality Move:
6.92%
Sell
27
Aptevo Therapeutics (APVO) is a Sell

Is Aptevo Therapeutics a Buy, Sell or Hold?

  • The current Aptevo Therapeutics [APVO] share price is $4.36. The Score for APVO is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • APVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $85.00. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

APVO Stock Price Chart

What is Aptevo Therapeutics's stock price today?

  • The Aptevo Therapeutics share price today is $4.36
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APVO is experiencing slight selling pressure.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $85.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.

APVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.47 Sell
Relative Strength Index (14 RSI): 35.08 Sell
Chaikin Money Flow: -43529 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.66 - 11.16) Sell
Bollinger Bands (100): (6.54 - 13.42) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.5 Sell
Relative Strength Index (14 RSI): 19.69 Sell
Chaikin Money Flow: 20899665 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.63 - 110.99) Sell
Bollinger Bands (100): (107.27 - 131.41) Sell

APVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.12 Sell
20-day SMA: 8.24 Sell
50-day SMA: 8.71 Sell
200-day SMA: 32.53 Sell
8-day EMA: 5.29 Sell
20-day EMA: 7.09 Sell
50-day EMA: 8.69 Sell
200-day EMA: 168.98 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104.71 Sell
20-day SMA: 106.65 Sell
50-day SMA: 109.28 Sell
200-day SMA: 126.25 Sell
8-day EMA: 102.07 Sell
20-day EMA: 105.53 Sell
50-day EMA: 110.02 Sell
200-day EMA: 118.09 Sell

Aptevo Therapeutics Earnings Growth & APVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $17.55 per share, a decrease next quarter of $0.00 per share, an increase this year of $3,536.34 per share, and an increase next year of $71.15 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.66 per share.

Aptevo Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):